Diamir Biosciences Corp. Watch

from S-1 14 pages Employment Agreement

from S-1 8 pages Employment Agreement

from S-1 9 pages Diamir Biosciences Corp. 2024 Stock Option Plan Section 1. Purpose

from S-1 10 pages Diamir Biosciences Corp. 2014 Stock Option Plan Section 1. Purpose

from S-1 5 pages Insider Stock Purchase Agreement

from S-1 5 pages *** Grants Specialist National Institute of Neurological Disorders and Stroke ***

from S-1 6 pages Federal Award Information

from S-1 7 pages *** National Institute on Aging ***

from S-1 5 pages Summary Federal Award Financial Information 19. Budget Period Start Date 05/01/2021 – End Date 04/30/2022 20. Total Amount of Federal Funds Obligated by This Action $ 1,484,214 20 A. Direct Cost Amount $ 990,797 20 B. Indirect Cost Amount $ 396,319 21. Authorized Carryover $ 0 22. Offset $ 0 23. Total Amount of Federal Funds Obligated This Budget Period $ 1,484,214 24. Total Approved Cost Sharing or Matching, Where Applicable $ 0 25. Total Federal and Non-Federal Approved This Budget Period $ 1,484,214 26. Project Period Start Date 07/01/2013 – End Date 04/30/2023 27. Total Amount of the Federal Award Including Approved Cost Sharing or Matching This Project Period $ 2,734,277 28. Authorized Treatment of Program Income Additional Costs 29. Grants Management Officer - Signature *** 30. Remarks Acceptance of This Award, Including the “Terms and Conditions,” Is Acknowledged by the Recipient When Funds Are Drawn Down or Otherwise Requested From the Grant Payment System

from S-1 5 pages Grant Number: 2r44ag044860-07 Fain: R44ag044860 Principal Investigator(s): Samuil R Umansky, MD Project Title: Brain-Enriched Micrornas Detectable in Plasma as Biomarkers of Alzheimer’s Disease Dr. Umansky, Samuil President, Chief Scientific Officer 3 Orchid Ct Princeton, Nj 085409429 Award E-Mailed To: Sumansky@diamirbio.com Period of Performance

from S-1 3 pages Amendment to Consulting Agreement

from S-1 7 pages Material contract

from S-1 14 pages Material contract

from DRS/A 14 pages Employment Agreement

from DRS/A 8 pages Employment Agreement

from DRS/A 5 pages *** Grants Specialist National Institute of Neurological Disorders and Stroke ***

from DRS/A 6 pages Federal Award Information

from DRS/A 7 pages *** National Institute on Aging ***

from DRS/A 5 pages Summary Federal Award Financial Information 19. Budget Period Start Date 05/01/2021 – End Date 04/30/2022 20. Total Amount of Federal Funds Obligated by This Action $ 1,484,214 20 A. Direct Cost Amount $ 990,797 20 B. Indirect Cost Amount $ 396,319 21. Authorized Carryover $ 0 22. Offset $ 0 23. Total Amount of Federal Funds Obligated This Budget Period $ 1,484,214 24. Total Approved Cost Sharing or Matching, Where Applicable $ 0 25. Total Federal and Non-Federal Approved This Budget Period $ 1,484,214 26. Project Period Start Date 07/01/2013 – End Date 04/30/2023 27. Total Amount of the Federal Award Including Approved Cost Sharing or Matching This Project Period $ 2,734,277 28. Authorized Treatment of Program Income Additional Costs 29. Grants Management Officer - Signature *** 30. Remarks Acceptance of This Award, Including the “Terms and Conditions,” Is Acknowledged by the Recipient When Funds Are Drawn Down or Otherwise Requested From the Grant Payment System

from DRS/A 5 pages Grant Number: 2r44ag044860-07 Fain: R44ag044860 Principal Investigator(s): Samuil R Umansky, MD Project Title: Brain-Enriched Micrornas Detectable in Plasma as Biomarkers of Alzheimer’s Disease Dr. Umansky, Samuil President, Chief Scientific Officer 3 Orchid Ct Princeton, Nj 085409429 Award E-Mailed To: Sumansky@diamirbio.com Period of Performance